Eduardo Pereira de Souza

Mr. Eduardo Pereira de Souza

Genetics and Evolution Department, Federal University of São Carlos, São Carlos, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MFMarjorie Freire
Marjorie Freire
GNGabriela D. Noske
Gabriela D. Noske
NBNatália V. Bitencourt
Natália V. Bitencourt
PSPaulo Ricardo da Silva Sanches
Paulo Ricardo da Silva Sanches
NSNorival A. Santos-Filho
Norival A. Santos-Filho
GOGlaucius Oliva
Glaucius Oliva
The COVID-19 outbreak has rapidly spread on a global scale, affecting the economy and public health systems throughout the world. In recent years, peptide-based therapeutics have been widely studied and developed to treat infectious diseases, including viral infections. Herein, the antiviral effects of the lysine linked dimer des-Cys11, Lys12,Lys13-(pBthTX-I)2K ((pBthTX-I)2K)) and derivatives against SARS-CoV-2 are reported. The lead peptide (pBthTX-I)2K and derivatives showed attractive inhibitory activities against SARS-CoV-2 (EC50 = 28–65 µM) and mostly low cytotoxic effect (CC50 > 100 µM). To shed light on the mechanism of action underlying the peptides’ antiviral activity, the Main Protease (Mpro) and Papain-Like protease (PLpro) inhibitory activities of the peptides were assessed. The synthetic peptides showed PLpro inhibition potencies (IC50s = 1.0–3.5 µM) and binding affinities (Kd = 0.9–7 µM) at the low micromolar range but poor inhibitory activity against Mpro (IC50 > 10 µM). The modeled binding mode of a representative peptide of the series indicated that the compound blocked the entry of the PLpro substrate toward the protease catalytic cleft. Our findings indicated that non-toxic dimeric peptides derived from the Bothropstoxin-I have attractive cellular and enzymatic inhibitory activities, thereby suggesting that they are promising prototypes for the discovery and development of new drugs against SARS-CoV-2 infection.

13 July 2022 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
VPVinícius Taioqui Pelá
Vinícius Taioqui Pelá
LBLeonardo Brito
Leonardo Brito
ETEven Akemi Taira
Even Akemi Taira
FHFlávio Henrique-Silva
Flávio Henrique-Silva
JPJoana Claudio Pieretti
Joana Claudio Pieretti
Marilia BuzalafMarilia Buzalaf
Marilia Buzalaf

4 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ESEduardo Pereira de Souza
Eduardo Pereira de Souza
MFMilene Ferro
Milene Ferro
VPVinicius Taioqui Pelá
Vinicius Taioqui Pelá
TCThais Fernanda Carlos
Thais Fernanda Carlos
CBCecília Guimarães Giannico Borges
Cecília Guimarães Giannico Borges
FHFlavio Henrique-Silva
Flavio Henrique-Silva
Phytocystatins are proteinaceous competitive inhibitors of cysteine peptidases involved in physiological and defensive roles in plants. Their application as potential therapeutics for human disorders has been suggested, and the hunt for novel cystatin variants in different plants, such as maqui (Aristotelia chilensis), is pertinent. Being an understudied species, the biotechnological potential of maqui proteins is little understood. In the present study, we constructed a transcriptome of maqui plantlets using next-generation sequencing, in which we found six cystatin sequences. Five of them were cloned and recombinantly expressed. Inhibition assays were performed against papain and human cathepsins B and L. Maquicystatins can inhibit the proteases in nanomolar order, except MaquiCPIs 4 and 5, which inhibit cathepsin B in micromolar order. This suggests maquicystatins’ potential use for treating human diseases. In addition, since we previously demonstrated the efficacy of a sugarcane-derived cystatin to protect dental enamel, we tested the ability of MaquiCPI-3 to protect both dentin and enamel. Both were protected by this protein (by One-way ANOVA and Tukey’s Multiple Comparisons Test, p < 0.05), suggesting its potential usage in dental products.

24 September 2025 in Journal of Dentistry
Verified
Journal Article
Closed access
VPVinícius Taioqui Pelá
Vinícius Taioqui Pelá
GSGustavo Cassalate da Silva
Gustavo Cassalate da Silva
MBMariana Miranda de Brito
Mariana Miranda de Brito
ETEven Akemi Taira
Even Akemi Taira
CFCarolina Ruis Ferrari
Carolina Ruis Ferrari
Marilia BuzalafMarilia Buzalaf
Marilia Buzalaf

13 November 2024 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
VPVinícius Taioqui Pelá
Vinícius Taioqui Pelá
MBMariana Miranda de Brito
Mariana Miranda de Brito
GSGustavo Cassalate da Silva
Gustavo Cassalate da Silva
ETEven Akemi Taira
Even Akemi Taira
CFCarolina Ruis Ferrari
Carolina Ruis Ferrari
Marilia BuzalafMarilia Buzalaf
Marilia Buzalaf

2 October 2018 in Journal of Plant Pathology
Verified
Journal Article
Closed access
PDF file
GCGiovana Carolina Dourado Cruciol
Giovana Carolina Dourado Cruciol
MMMônika Fecury Moura
Mônika Fecury Moura
Marcos Ribeiro-JuniorMarcos Ribeiro-Junior
Marcos Ribeiro-Junior
VEViviane Yoshimi Egawa
Viviane Yoshimi Egawa
ESEduardo Pereira de Souza
Eduardo Pereira de Souza
RKRenate Krause-Sakate
Renate Krause-Sakate